Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Brain, Body, Cognition - A continuation of Functional Neurology, Rehabilitation and Ergonomics
$325.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Methicillin-Resistant Staphylococcus Aureus (MRSA): Etiology, At-Risk Populations and Treatment
Tell A Friend
 
Tell someone you know about this product.
Methicillin-Resistant Staphylococcus Aureus (MRSA): Etiology, At-Risk Populations and Treatment
Retail Price: $395.00
10% Online Discount
You Pay:

$355.50
Editors: Charles L. Kolendi
Book Description:
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a bacterium responsible for difficult-to-treat infections in humans. It may also be referred to as multidrug-resistant Staphylococcus aureus. MRSA is by definition a strain of Staphylococcus aureus that is resistant to a large group of antibiotics called the beta-lactams, which include the penicillins and the cephalosporins. MRSA was identified as a nosocomial pathogen in the 1960's. MRSA acquisition has traditionally been linked to health care settings and specific patient populations. Established risk factors for MRSA infection include older age, recent hospitalization or surgery, past antimicrobial therapy, residence in a long-term care facility, dialysis, indwelling percutaneous devices and cathethers. This new and important book gathers the latest research from around the globe in this field and focuses on such topics as: risk factors for MRSA in a pediatric surgical ward, MRSA treatments, the anatomy of an outbreak, and others.

We’ve partnered with Copyright Clearance Center to make it easy for you to request permissions to reuse Nova content.
For more information, click here or click the "Get Permission" button below to link directly to this book on Copyright Clearance Center's website.


Table of Contents:
Preface

Chapter 1. The Case for MRSA and Treatment of Methicilllin Resistant Staphylococcus aureus, pp. 1-54
(Professor Manal M. Baddour, Microbiology and Immunology Dept., Faculty of Medicine, Alexandria University, Alexandria, Egypt)

Chapter 2. Therapeutic options for intracellular MRSA: Current views and perspectives, pp. 55-74
(Sandrine Lemaire, Paul M. Tulkens and Françoise Van Bambeke
Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium)^

Chapter 3. Methicillin-Resistant Staphylococcus Aureus (MRSA), pp. 75-141
(Dong Choon Park, Sun Kyu Lee, Seung Geun Yeo, Department of Obstetrics and Gynecology, The Catholic University of Korea, Seoul, Korea and others)

Chapter 4. Hospital and Community-Acquired Methicillin-Resistant Staphylococcus Aureus Bone and Joint Infections, pp. 143-209
(Ilker Uçkay, Frederic Laurent, Sébastien Lustig, Jean-Philippe Rasigade, Vivien Thomson, Vincent Paoli, Thomas Perpoint, Richard Stern, André Boibieux, Florence Ader, Gerard Lina, Daniel Lew, François Vandenesch, Dominique Peyramond, Christian Chidiac, Jerome Etienne, and Tristan Ferry, Service de Maladies Infectieuses, Hôpitaux Universitaires de Genève, Suisse)

Chapter 5. MRSA: The Virulence, Epidemiology and Perspective Diagnostics and Therapy, pp. 211-256
(Julianna Kurlenda, Mariusz Grinholc, Department of Clinical Bacteriology in Hospital, Monte Cassino, Koszalin, Poland, and others)

Chapter 6. Recent Advances in Medicinal Chemistry of New Quinolones with Potential Anti-MRSA Activity, pp. 257-328
(Saeed Emami, Department of Medicinal Chemistry, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran)

Chapter 7. Methicillin-Resistant Staphylococcus aureus: Etiology, At-Risk Populations and Treatment, pp. 329-364
(Assoc. Prof. Dr. Mine Hosgor-Limoncu, Assoc. Prof. Dr. Safak Ermertcan, Assist Prof. Dr. Huseyin Tasli, Assist Prof. Dr. Bayrý Erac, Ayse Nur Yurtman, Ege University Faculty of Pharmacy, Department of Pharmaceutical Microbiology, Izmir,Turkey)

Chapter 8. Multidrug-Resistant Acinetobacter Baumannii Infections: Characteristics and Treatment Options, pp. 365-396
(A. Rodríguez- Guardado, A. Blanco, F. Pérez, M. Lantero, M. Álvarez Vega, J.M. Torres, JA Cartón, Infectious Diseases Unit, Hospital Universitario Central de Asturias, Spain)

Chapter 9. The Anatomy of an Outbreak: Lessons Learned from an Outbreak of Methicillin-Resistant Staphylococcus aureus Among Newborns and a Review of the Literature, pp. 397-419
(Nevio Cimolai, Department of Pathology and Laboratory Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada)

Chapter 10. The Emerging and the Re-Emerging of Antimicrobial-Resistant Gram-Positive Cocci: Evidences Supporting Novel Pharmaceutical Weapons, pp. 421-443
(Roberto Manfredi, Department of Internal Medicine, Aging, and Nephrologic Diseases, Division of Infectious Diseases, “Alma Mater Studiorum” University of Bologna, S. Orsola Hospital, Bologna, Italy)

Chapter 11. DHEA-Mediated Phenotypic Alterations in Staphylococcal Cell Wall Architecture, pp. 445-462
(Balbina J. Plotkin and Monika I. Konakleiva, Department of Microbiology, Midwestern University, Downers Grove, IL and others)

Chapter 12. Risk Factors for Carrying Methicillin-Resistant Staphylococcus aureus at Hospitalization in a Pediatric Surgical Ward, pp. 463-482
(Koichi Ohno, Department of Pediatric Surgery, Osaka City General Hospital, Osaka, Japan)

Chapter 13. Populations At-Risk for Methicillin-Resistant Staphylococcus aureus Infection, pp. 483-493
(Tze Shien Lo, Augusto M. Alonto, Stephanie M. Borchardt, Fargo Veterans Administration Medical Center, Fargo, North Dakota and others)

Chapter 14. Staphylococcus aureus: Risk Factors for Oronasal Transmission and Dental Aspect, pp. 495-500
(E. Bahar Tuna, Nursen Topcuoglu, Koray Gencay, Guven Kulekci, Istanbul University Faculty of Dentistry, Istanbul, Turkey)

Chapter 15. Community-Associated Methicillin-Resistant Staphylococcus aureus: Etiology, Diagnosis, Prevention and Treatment, pp. 501-507
(H. Richard Weiner, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin)

Chapter 16. Community-Acquired Methicillin-resistant Staphylococcus aureus: Characterization, Risk Factors, and Treatment, pp. 509-512
(Hossam M. Ashour, Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Egypt)

Chapter 17. The Changing Pattern of Infections with MRSA and Other Organisms after Major Reconstructive Surgery of the Maxillofacial Region ^, pp. 513-531
(CME Avery, University Hospitals of Leicester, United Kingdom)

Chapter 18. The Phenomenon of Antibiotic Resistance in an Evolutionary Perspective, pp. 533-535
(Roberto Manfredi, Department of Internal Medicine, Aging, and Nephrologic Diseases, Division of Infectious Diseases, “Alma Mater Studiorum” University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy)

Index pp.537-562

   Series:
      Bacteriology Research Developments
   Binding: Hardcover
   Pub. Date: 2009
   Pages: 562.pp
   ISBN: 978-1-60741-398-1
   Status: AV
  
Status Code Description
AN Announcing
FM Formatting
PP Page Proofs
FP Final Production
EP Editorial Production
PR At Prepress
AP At Press
AV Available
  
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2020

Methicillin-Resistant Staphylococcus Aureus (MRSA): Etiology, At-Risk Populations and Treatment